Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.
source https://www.sciencedaily.com/releases/2024/06/240619182323.htm
Gold 'supraballs' nearly double solar energy absorption in tests
-
Sunbeams contain a lot of energy. But current technology for harvesting
solar power doesn't capture as much as it could. Now, in ACS Applied
Materials & In...
7 hours ago
No comments:
Post a Comment